Build your foundation. Avoid costly mistakes. Get grounded in the essentials of export controls and compliance. This session covers the key regulations, common pitfalls (including dual-use items), and why compliance matters – because mistakes can carry serious consequences. Perfect for…
Justice: Florida Man Sentenced for $5M Biochemical Wire Fraud Scheme
Justice: Florida Man Sentenced for $5M Biochemical Wire Fraud Scheme
August 7, 2024/
Pen Yu was sentenced in Tampa to three years, eight months in federal prison for conspiracy to commit wire fraud. He ordered biochemical products from Millipore Sigma (subsidiary of Merck), falsely representing that he was affiliated with a Florida university's research lab. He got nearly $5 million in discounts and other benefits not available to the public. The products were shipped to the university stockroom, where an employee held them for Yu, who then repackaged them and sent them to China. Millipore's compliance personnel ID'd suspicious orders, which led to the discovery of the scheme.
Related Posts
NMFS: Upcoming Import Prohibitions and Industry Webinars
The National Marine Fisheries Service (NMFS) announces that, effective January 1, 2026, imports of specific fish and fish products from countries whose fisheries have not received comparability findings under the Marine Mammal Protection Act (MMPA) will be restricted from entering the United States. To help industry prepare for these changes, NMFS will host two informational…
CBP: Settlement Reached in Aluminum Extrusions Duty Evasion Case
Harman International Industries, parent company of Harman Kardon®, JBL®, and Mark Levinson®-has agreed to pay $11,809,628 to settle allegations that it evaded antidumping and countervailing duties (ADCVD) on aluminum-extrusion heatsinks imported from China. According to the allegations, the company failed for more than a decade to disclose or correct the violations and actively concealed the…
USTR: U.S. and U.K. Reach Agreement on Pharmaceuticals and Medical Technology
On December 1, 2025, the United States and United Kingdom announced a new agreement on pharmaceuticals, pharmaceutical ingredients, and medical technology. Under this arrangement, the U.S. would remove Section 232 tariffs on U.K.-sourced medical goods, pause any Section 301 investigations related to U.K. pharmaceutical pricing during President Trump’s term, and collaborate to expand U.K. patient…
FDA: Agency Deploys Agentic AI Capabilities for Staff Use
The U.S. Food and Drug Administration announced the rollout of agency-wide agentic AI tools designed to support employees with complex, multi-step tasks. These systems build on the FDA’s earlier deployment of its LLM-based tool, Elsa-currently used voluntarily by a majority of staff-and introduce more advanced features for workflow automation, planning, and reasoning. Participation remains optional,…